Skip to main content

Table 1 Treatment arms

From: Quick efficacy seeking trial (QuEST1): a novel combination immunotherapy study designed for rapid clinical signal assessment metastatic castration-resistant prostate cancer

Treatment Regimen for Any Solid Tumor
 Arm 1.1 M7824 + ALT-803
Treatment Regimen for mCRPC
 Arm 2.1: BN-Brachyury + M7824
 Arm 2.2: BN-Brachyury + M7824 + ALT-803
 Arm 2.3: BN-Brachyury + M7824 + ALT-803 + epacadostat